{"transactions":[{"id":1300340,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-17T18:08:28.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effective grant date of January 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU vests over a four-year period: 1/4 on Febuary 15, 2026, after which 1/4 of the total shares vest annually, subject to contioued service through each vestiog date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU vests over a four-year period: 1/4 on Febuary 15, 2026, after which 1/4 of the total shares vest annually, subject to contioued service through each vestiog date."}],"balance_after":16500,"derivative":{"underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-001723","document":"form4-01172025_110124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588925001723/form4-01172025_110124.xml","form_type":"4"}},{"id":1300339,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-17T18:08:28.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":132000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effective grant date of January 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a four-year period: 2.0833% shall vest on February 15, 2025, after which 2.0833% of the total shares vest monthly, subject to contioued service through each vestiog date."}],"balance_after":132000,"derivative":{"exercise_price":6,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":132000},"source":{"system":"sec-edgar","filing":"0001415889-25-001723","document":"form4-01172025_110124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588925001723/form4-01172025_110124.xml","form_type":"4"}},{"id":1369239,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Option Grant (right to buy)","published_at":"2024-11-12T17:08:24.000Z","date":"2024-11-08","kind":"exercise","planned":true,"acquired":false,"shares":2117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":368918,"derivative":{"exercise_price":4.2,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":2117},"source":{"system":"sec-edgar","filing":"0001415889-24-026626","document":"form4-11122024_101120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924026626/form4-11122024_101120.xml","form_type":"4"}},{"id":1369238,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-12T17:08:24.000Z","date":"2024-11-08","kind":"sale","planned":true,"acquired":false,"shares":2117,"price":15,"value":31755.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated March 27, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-026626","document":"form4-11122024_101120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924026626/form4-11122024_101120.xml","form_type":"4"}},{"id":1369237,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-12T17:08:24.000Z","date":"2024-11-08","kind":"exercise","planned":true,"acquired":true,"shares":2117,"price":4.2,"value":8891.4,"ownership":{"direct":true},"balance_after":2117,"source":{"system":"sec-edgar","filing":"0001415889-24-026626","document":"form4-11122024_101120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924026626/form4-11122024_101120.xml","form_type":"4"}},{"id":1379483,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Option Grant (right to buy)","published_at":"2024-10-30T16:17:58.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":false,"shares":2673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":371035,"derivative":{"exercise_price":4.2,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":2673},"source":{"system":"sec-edgar","filing":"0001415889-24-025750","document":"form4-10302024_081054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924025750/form4-10302024_081054.xml","form_type":"4"}},{"id":1379482,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-10-30T16:17:58.000Z","date":"2024-10-28","kind":"sale","planned":true,"acquired":false,"shares":2673,"price":15,"value":40095.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated March 27, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-025750","document":"form4-10302024_081054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924025750/form4-10302024_081054.xml","form_type":"4"}},{"id":1379481,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-10-30T16:17:58.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":true,"shares":2673,"price":4.2,"value":11226.6,"ownership":{"direct":true},"balance_after":2673,"source":{"system":"sec-edgar","filing":"0001415889-24-025750","document":"form4-10302024_081054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924025750/form4-10302024_081054.xml","form_type":"4"}},{"id":1401721,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Option Grant (right to buy)","published_at":"2024-09-20T17:36:08.000Z","date":"2024-09-19","kind":"exercise","planned":true,"acquired":false,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":373708,"derivative":{"exercise_price":4.2,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":4790},"source":{"system":"sec-edgar","filing":"0001415889-24-023788","document":"form4-09202024_090904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924023788/form4-09202024_090904.xml","form_type":"4"}},{"id":1401720,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-20T17:36:08.000Z","date":"2024-09-19","kind":"sale","planned":true,"acquired":false,"shares":4790,"price":15,"value":71850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated May 15, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-023788","document":"form4-09202024_090904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924023788/form4-09202024_090904.xml","form_type":"4"}},{"id":1401719,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-20T17:36:08.000Z","date":"2024-09-19","kind":"exercise","planned":true,"acquired":true,"shares":4790,"price":4.2,"value":20118.0,"ownership":{"direct":true},"balance_after":4790,"source":{"system":"sec-edgar","filing":"0001415889-24-023788","document":"form4-09202024_090904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000141588924023788/form4-09202024_090904.xml","form_type":"4"}},{"id":1682956,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Option Grant (right to buy)","published_at":"2024-01-09T16:06:05.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":133000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period: 1/48th on February 5, 2024, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":133000,"derivative":{"exercise_price":10.89,"expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":133000},"source":{"system":"sec-edgar","filing":"0001209191-24-001233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919124001233/doc4.xml","form_type":"4"}},{"id":1719216,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Option Grant (right to buy)","published_at":"2023-12-07T16:03:55.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":true,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total shares vested on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":378498,"derivative":{"exercise_price":4.2,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":4790},"source":{"system":"sec-edgar","filing":"0001209191-23-057712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123057712/doc4.xml","form_type":"4"}},{"id":1719215,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-07T16:03:55.000Z","date":"2023-12-05","kind":"sale","planned":true,"acquired":false,"shares":4790,"price":10.0339,"value":48062.381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated May 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-057712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123057712/doc4.xml","form_type":"4"}},{"id":1719214,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-07T16:03:55.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":true,"shares":4790,"price":4.2,"value":20118.0,"ownership":{"direct":true},"balance_after":4790,"source":{"system":"sec-edgar","filing":"0001209191-23-057712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123057712/doc4.xml","form_type":"4"}},{"id":1963656,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-08T17:00:42.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":137000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":137000,"derivative":{"exercise_price":4.2,"expiration_date":"2033-03-05","underlying":"Common Stock","underlying_shares":137000},"source":{"system":"sec-edgar","filing":"0001209191-23-017233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123017233/doc4.xml","form_type":"4"}},{"id":1963655,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-08T17:00:42.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":95000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":95000,"derivative":{"exercise_price":4.2,"expiration_date":"2032-10-24","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-23-017233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123017233/doc4.xml","form_type":"4"}},{"id":1963654,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-08T17:00:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":95000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":18.4,"expiration_date":"2032-10-24","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-23-017233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123017233/doc4.xml","form_type":"4"}},{"id":1963653,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-08T17:00:42.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":383288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":383288,"derivative":{"exercise_price":4.2,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":383288},"source":{"system":"sec-edgar","filing":"0001209191-23-017233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123017233/doc4.xml","form_type":"4"}},{"id":1963652,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-08T17:00:42.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":383288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":8.61,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":383288},"source":{"system":"sec-edgar","filing":"0001209191-23-017233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123017233/doc4.xml","form_type":"4"}},{"id":2131144,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Option Grant (right to buy)","published_at":"2022-10-27T16:47:07.000Z","date":"2022-10-25","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 6-month period: 1/6th on October 25, 2022, after which 1/6th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":95000,"derivative":{"exercise_price":18.4,"expiration_date":"2032-10-24","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-22-054724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919122054724/doc4.xml","form_type":"4"}},{"id":2244845,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-03T20:19:47.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant."}],"balance_after":8500,"derivative":{"exercise_price":1.07,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-22-034387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000120919122034387/doc4.xml","form_type":"4"}},{"id":2650139,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-30T18:44:14.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":7728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant."}],"balance_after":7728,"derivative":{"exercise_price":8.12,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":7728},"source":{"system":"sec-edgar","filing":"0001209191-21-044076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000120919121044076/doc4.xml","form_type":"4"}},{"id":3171137,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-23T07:36:01.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":15457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal installments on April 22, 2021, 2022 and 2023."}],"balance_after":15457,"derivative":{"exercise_price":16,"expiration_date":"2030-04-21","underlying":"Common Stock","underlying_shares":15457},"source":{"system":"sec-edgar","filing":"0000899243-20-011202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000089924320011202/doc4.xml","form_type":"4"}},{"id":3311031,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-15T13:26:41.000Z","date":"2020-01-15","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":36.08,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-20-003426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000120919120003426/doc4.xml","form_type":"4"}},{"id":3311030,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-15T13:26:41.000Z","date":"2020-01-15","kind":"other","acquired":false,"shares":24584,"price":60,"value":1475040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 2, 2019, Audentes Therapeutics, Inc. (the \"Company\") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the \"Merger Agreement\") with Astellas Pharma Inc. (\"Astellas\") and Asilomar Acquisition Corp., a wholly-owned subsidiary of Astellas (\"Merger Sub\"), pursuant to which Astellas acquired the Company by a tender offer for all shares of Company common stock (the \"Offer\") and a subsequent merger (the \"Merger\"), each of which became effective on January 15, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $60.00 per share (the \"Offer Price\") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were canceled and converted automatically into the right to receive the Offer Price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company restricted stock units, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company restricted stock unit was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such Company restricted stock unit immediately prior to such cancellation by (ii) an amount in cash equal to the Offer Price, without any interest."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 18,750 shares of Company common stock issuable upon the settlement of restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-003426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000120919120003426/doc4.xml","form_type":"4"}},{"id":3341032,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-16T18:02:30.000Z","date":"2019-12-12","kind":"tax_withholding","acquired":false,"shares":5416,"price":59.37,"value":321547.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On December 10, 2019, the Compensation Committee of the Issuer's Board of Directors approved the accelerated vesting and settlement of restricted stock units granted on July 15, 2019 in order to mitigate the potential adverse tax consequences of Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes."}],"balance_after":24584,"source":{"system":"sec-edgar","filing":"0001209191-19-060727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000120919119060727/doc4.xml","form_type":"4"}},{"id":3460011,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-17T16:26:50.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest as to 25% of the total shares on July 15, 2020, and then 2.0833% of the shares will vest monthly thereafter such that the option is fully vested on July 15, 2023, subject to the Reporting Person's provision of service to the issuer on each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":36.08,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-19-042379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000120919119042379/doc4.xml","form_type":"4"}},{"id":3460010,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-17T16:26:50.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's Common Stock upon settlement for no consideration. The RSUs will vest as to 25% of the award on September 5, 2020, and then 6.25% of the RSUs will vest quarterly thereafter on each of December 5, March 5, June 5, and September 5 of a given calendar year, such that the RSUs are fully vested on September 5, 2023, subject to the Reporting Person's provision of services to the issuer on each vesting date. Shares of the issuer's Common Stock will be delivered to the Reporting Person following vesting."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-19-042379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691265/000120919119042379/doc4.xml","form_type":"4"}},{"id":3685809,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-28T22:46:59.000Z","date":"2019-01-24","kind":"tax_withholding","acquired":false,"shares":834,"price":11.1,"value":9257.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of the restricted stock unit grant that vested on January 24, 2019 surrendered by the Reporting Person to\nthe Issuer for tax withholding, using the Issuer's closing stock price on January 24, 2019 of $11.10/share, pursuant to the terms of the Issuer's 2013\nStock Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,208 shares resulting from the January 24, 2019 vesting of Reporting Person's January 24, 2018 restricted stock unit grant and 4,083\nshares subject to such restricted stock unit grant that will vest in two (2) additional equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer\nthrough such date."}],"balance_after":11291,"source":{"system":"sec-edgar","filing":"0001209191-19-005621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119005621/doc4.xml","form_type":"4"}},{"id":3701058,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-08T22:38:25.000Z","date":"2019-01-07","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":130000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-002871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119002871/doc4.xml","form_type":"4"}},{"id":3701057,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-08T22:38:25.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":5000,"price":12.3261,"value":61630.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $12.17 to $12.44 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12125,"source":{"system":"sec-edgar","filing":"0001209191-19-002871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119002871/doc4.xml","form_type":"4"}},{"id":3701056,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-08T22:38:25.000Z","date":"2019-01-07","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":17125,"source":{"system":"sec-edgar","filing":"0001209191-19-002871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119002871/doc4.xml","form_type":"4"}},{"id":3740185,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-08T00:46:19.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":135000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-061668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118061668/doc4.xml","form_type":"4"}},{"id":3740184,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-08T00:46:19.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":5000,"price":11.4866,"value":57433.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $11.31 to $11.78 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12125,"source":{"system":"sec-edgar","filing":"0001209191-18-061668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118061668/doc4.xml","form_type":"4"}},{"id":3740183,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-08T00:46:19.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":17125,"source":{"system":"sec-edgar","filing":"0001209191-18-061668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118061668/doc4.xml","form_type":"4"}},{"id":3771815,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-07T22:41:09.000Z","date":"2018-11-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":140000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-057677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118057677/doc4.xml","form_type":"4"}},{"id":3771814,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-07T22:41:09.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":5000,"price":13.73,"value":68650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $13.56 to $13.85 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12125,"source":{"system":"sec-edgar","filing":"0001209191-18-057677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118057677/doc4.xml","form_type":"4"}},{"id":3771813,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-07T22:41:09.000Z","date":"2018-11-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date.  Includes 2,000 shares acquired by the Reporting Person on October 31, 2018 under the Issuer's 2010 Employee Stock Purchase Plan, as amended."}],"balance_after":17125,"source":{"system":"sec-edgar","filing":"0001209191-18-057677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118057677/doc4.xml","form_type":"4"}},{"id":3795264,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-09T21:40:58.000Z","date":"2018-10-08","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":145000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-054573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118054573/doc4.xml","form_type":"4"}},{"id":3795263,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-09T21:40:58.000Z","date":"2018-10-08","kind":"sale","acquired":false,"shares":5000,"price":14.5547,"value":72773.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $14.39 to $14.79 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001209191-18-054573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118054573/doc4.xml","form_type":"4"}},{"id":3795262,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-09T21:40:58.000Z","date":"2018-10-08","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":15125,"source":{"system":"sec-edgar","filing":"0001209191-18-054573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118054573/doc4.xml","form_type":"4"}},{"id":3822595,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-07T20:39:02.000Z","date":"2018-09-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":150000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-050085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118050085/doc4.xml","form_type":"4"}},{"id":3822594,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-07T20:39:02.000Z","date":"2018-09-06","kind":"sale","acquired":false,"shares":5000,"price":14.169,"value":70845.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $13.100 to $15.175 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001209191-18-050085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118050085/doc4.xml","form_type":"4"}},{"id":3822593,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-07T20:39:02.000Z","date":"2018-09-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":15125,"source":{"system":"sec-edgar","filing":"0001209191-18-050085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118050085/doc4.xml","form_type":"4"}},{"id":3851120,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-07T23:28:29.000Z","date":"2018-08-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":155000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-045758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118045758/doc4.xml","form_type":"4"}},{"id":3851119,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-07T23:28:29.000Z","date":"2018-08-06","kind":"sale","acquired":false,"shares":5000,"price":13.45,"value":67250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001209191-18-045758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118045758/doc4.xml","form_type":"4"}},{"id":3851118,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-07T23:28:29.000Z","date":"2018-08-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":15125,"source":{"system":"sec-edgar","filing":"0001209191-18-045758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118045758/doc4.xml","form_type":"4"}},{"id":3871331,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-09T22:58:44.000Z","date":"2018-07-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":160000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-042044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118042044/doc4.xml","form_type":"4"}},{"id":3871330,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-09T22:58:44.000Z","date":"2018-07-06","kind":"sale","acquired":false,"shares":5000,"price":15.795,"value":78975.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $15.50 to $15.95 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001209191-18-042044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118042044/doc4.xml","form_type":"4"}},{"id":3871329,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-09T22:58:44.000Z","date":"2018-07-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":15125,"source":{"system":"sec-edgar","filing":"0001209191-18-042044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118042044/doc4.xml","form_type":"4"}},{"id":3902358,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-07T20:06:45.000Z","date":"2018-06-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":165000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-036325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118036325/doc4.xml","form_type":"4"}},{"id":3902357,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-07T20:06:45.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":5000,"price":16.67,"value":83350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $16.55 to $16.95 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001209191-18-036325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118036325/doc4.xml","form_type":"4"}},{"id":3902356,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-07T20:06:45.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":15125,"source":{"system":"sec-edgar","filing":"0001209191-18-036325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118036325/doc4.xml","form_type":"4"}},{"id":3941523,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-09T21:38:14.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":170000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-028954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118028954/doc4.xml","form_type":"4"}},{"id":3941522,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-09T21:38:14.000Z","date":"2018-05-07","kind":"sale","acquired":false,"shares":5000,"price":16.3628,"value":81814.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $16.25 to $16.60 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date.  Includes 2,000 shares acquired by the Reporting Person on April 30, 2018 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001209191-18-028954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118028954/doc4.xml","form_type":"4"}},{"id":3941521,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-09T21:38:14.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date.  Includes 2,000 shares acquired by the Reporting Person on April 30, 2018 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":15125,"source":{"system":"sec-edgar","filing":"0001209191-18-028954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118028954/doc4.xml","form_type":"4"}},{"id":3967168,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-09T22:43:30.000Z","date":"2018-04-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":175000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-024422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118024422/doc4.xml","form_type":"4"}},{"id":3967167,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-09T22:43:30.000Z","date":"2018-04-06","kind":"sale","acquired":false,"shares":5000,"price":17.413,"value":87065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $16.95 to $17.85 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":8125,"source":{"system":"sec-edgar","filing":"0001209191-18-024422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118024422/doc4.xml","form_type":"4"}},{"id":3967166,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-09T22:43:30.000Z","date":"2018-04-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":13125,"source":{"system":"sec-edgar","filing":"0001209191-18-024422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118024422/doc4.xml","form_type":"4"}},{"id":4009005,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-08T01:43:34.000Z","date":"2018-03-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":180000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-017884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118017884/doc4.xml","form_type":"4"}},{"id":4009004,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-08T01:43:34.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":5000,"price":24.7755,"value":123877.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $24.20 to $25.20 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":8125,"source":{"system":"sec-edgar","filing":"0001209191-18-017884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118017884/doc4.xml","form_type":"4"}},{"id":4009003,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-08T01:43:34.000Z","date":"2018-03-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":13125,"source":{"system":"sec-edgar","filing":"0001209191-18-017884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118017884/doc4.xml","form_type":"4"}},{"id":4072616,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-07T22:17:17.000Z","date":"2018-02-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":185000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-008165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118008165/doc4.xml","form_type":"4"}},{"id":4072615,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-07T22:17:17.000Z","date":"2018-02-06","kind":"sale","acquired":false,"shares":5000,"price":18.4871,"value":92435.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $18.05 to $18.80 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":8125,"source":{"system":"sec-edgar","filing":"0001209191-18-008165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118008165/doc4.xml","form_type":"4"}},{"id":4072614,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-07T22:17:17.000Z","date":"2018-02-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":13125,"source":{"system":"sec-edgar","filing":"0001209191-18-008165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118008165/doc4.xml","form_type":"4"}},{"id":4083865,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-01T01:10:04.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":36750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 24, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":36750,"derivative":{"exercise_price":20.05,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":36750},"source":{"system":"sec-edgar","filing":"0001209191-18-006335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118006335/doc4.xml","form_type":"4"}},{"id":4083864,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-01T01:10:04.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":6125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":8125,"source":{"system":"sec-edgar","filing":"0001209191-18-006335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118006335/doc4.xml","form_type":"4"}},{"id":4102309,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-10T22:51:36.000Z","date":"2018-01-08","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":190000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118003159/doc4.xml","form_type":"4"}},{"id":4102308,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-10T22:51:36.000Z","date":"2018-01-08","kind":"sale","acquired":false,"shares":5000,"price":17.109,"value":85545.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $16.90 to $17.40 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-18-003159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118003159/doc4.xml","form_type":"4"}},{"id":4102307,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-10T22:51:36.000Z","date":"2018-01-08","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,000 shares acquired by the Reporting Person on October 31, 2017 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-18-003159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118003159/doc4.xml","form_type":"4"}},{"id":4138383,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-08T23:53:04.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":195000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-064858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117064858/doc4.xml","form_type":"4"}},{"id":4138382,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-08T23:53:04.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":5000,"price":16.24,"value":81200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $16.10 to $16.35 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-064858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117064858/doc4.xml","form_type":"4"}},{"id":4138381,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-08T23:53:04.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":5000,"price":3.2,"value":16000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-17-064858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117064858/doc4.xml","form_type":"4"}},{"id":4535840,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":74160,"kind":"person","name":"Conner Edward R.","position":1,"cik":"0001691265","reported_name":"Conner Edward R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CMO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-02T22:23:47.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-quarter (1/4) of the option shares will vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":200000,"derivative":{"exercise_price":3.2,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-16-088669","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036116088669/doc1.xml","form_type":"4"}}]}